Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as
Case Western Reserve´s new vice president for research, effective this month.
Rivera, the university´s associate vice president for research since January 2011,
emerged as the top choice after an extensive process involving campuswide nominations
of internal university candidates. Since coming to CWRU, Rivera has distinguished herself
through a commitment to collaboration and a focus on systems and processes.
Read more about her.
Click here to view previous editions of Research Matters and Research News and Updates.
December 9, 2014
NIH Change to annual progress reports received on/after 10/1/14
National Institutes of Health (NIH) annual progress reports received on or after October 1, 2014 must include a section to describe how individual development plans (IDPs) are used to identify and promote the career goals of graduate students and postdoctoral researchers associated with the award.
New Facilities and Administrative (F&A) Rate for Use in Proposals
Negotiations with the Department of Health and Human Services (DHHS) regarding the University’s F&A rates have concluded. DHHS has approved a (3) three year F&A rate of 58.5% for CWRU, which is a 1.5 percentage point change from our previous rate of 57%. This rate will be effective through June 2016.
The new F&A rate should be used when preparing proposal budgets for awards with an anticipated start date of July 1, 2013 or after.
New Policy from NIH to Balance Sex in Cell and Animal Studies
NIH announced last week a new policy requiring "a balance of male and female cells and animals in preclinical studies in all future applications." In this week's Nature, Janine Clayton and Francis Collins write, "The over-reliance on male animals and cells in preclinical research obscures key sex differences that could guide clinical studies. And it might be harmful: women experience higher rates of adverse drug reactions than men do. Furthermore, inadequate inclusion of female cells and animals in experiments and inadequate analysis of data by sex may well contribute to the troubling rise of irreproducibility in preclinical biomedical research."
The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.
The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.
Contact Joe Peter at 216-702-5314 for more information.
Sparta Frequently Asked Questions (FAQs)
CWRU's Office of Research Administration has recently added a page to its website listing answers to some of the common questions we get from Sparta users. These Frequently Asked Questions, or FAQs, range from what to do for specific error messages to how to handle common confusing situations in Sparta. We will continue to add to these FAQs, and are always open to suggestions. These questions are searchable with your browser search feature so you can look for specific keywords if you like.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be